The National Osteoporosis Foundation (NOF) launches new resources including interactive digital tool, podcast and first-of-its-kind patient registry in honor of 35th Anniversary ARLINGTON, VA (April 22, 2019) — NOF is celebrating National Osteoporosis Month in May and its 35th Anniversary with the launch of new resources designed to help people of all ages understand the… Read more »
News
FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture »
One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS,… Read more »
National Bone Health Policy Institute Responds to Proposed Rules »
NOF on behalf of the NBHPI has submitted comments to CMS and HHS regarding proposed rules that could impact osteoporosis patients access to testing and treatment. Comment letters have been submitted for the following: December 31, 2019 – Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs CMS-5528-ANPRM January 25,… Read more »
NOF Response to New York Times’ article: “Spinal Fractures Can Be Terribly Painful. A Common Treatment Isn’t Helping” »
NOF Statement in Response to the New York Times’ article: “Spinal Fractures Can Be Terribly Painful. A Common Treatment Isn’t Helping” by Gina Kolata, January 24, 2019. We appreciate the New York Times’ coverage of spinal fractures and two procedures used to treat them (vertebroplasty and kyphoplasty), but we have serious concerns with its implication… Read more »
Protecting Patient Access to Medication (Updated) »
Dear Members of Congress: We want to express our concern regarding any proposal that would repeal the non-interference (NI) clause – a crucial fixture and protection in the Medicare Part D program. We are concerned that changes to the Part D NI clause could undermine the private negotiations that enable seniors to access affordable prescription… Read more »
Protecting Patient Access to Medication »
Dear Members of Congress: We want to express our concern regarding any proposal that would repeal the non-interference (NI) clause – a crucial fixture and protection in the Medicare Part D program. We are concerned that changes to the Part D NI clause could undermine the private negotiations that enable seniors to access affordable prescription… Read more »
Bindex Measurement Revolutionizes Osteoporosis Diagnostics in US »
Bone Index Ltd., a medical device company with game-changing point-of-care technology (Bindex®) in osteoporosis diagnostics, announces that one million patients have been measured with Bindex® in the U.S. in 2018. Earlier this year, the American Medical Association issued a new reimbursement code* for Bindex® and the Centers for Medicare & Medicaid Services (CMS) has approved… Read more »
Did you know that weak bones are not a normal part of aging? »
The National Osteoporosis Foundation Debunks Myths Surrounding Osteoporosis and the Risk of Fractures While osteoporosis does cause bones to become weak and fragile, so that they break easily – even from a minor fall or a sneeze – osteoporosis is not a normal part of aging.  It is a disease that is common, serious and… Read more »
NOF Adds to its Mission Department »
The National Osteoporosis Foundation (NOF), the nation’s leading health organization solely dedicated to osteoporosis and bone health, announced the addition of two thoughtful new leaders to its newly designated Mission department, underscoring the organization’s commitment to delivering quality educational programming for patients and healthcare professionals. Samantha Mayberry joins NOF as the Associate Director of Patient… Read more »
NOF Statement on Medicare Part B »
Washington, DC (October 25, 2018) – The National Osteoporosis Foundation issued the following statement regarding announced changes the Medicare Part B program: “Medicare Part B is vital to patients living with and managing chronic illnesses, like osteoporosis. Key to treatment under the program is the ability for doctors and patients to tailor care to the… Read more »